Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
1 other identifier
interventional
200
1 country
13
Brief Summary
This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities. Previous research had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state. The goal is to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns. The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners. The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 26, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2029
July 6, 2026
June 1, 2026
2.3 years
June 26, 2026
June 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Statewide Capacity Assessment Scores for Lung Cancer Screening Implementation and Sustainability Capacity
Statewide capacity will be assessed using the State Team Assessment (STA) and Coalition Assessment (CA) instruments. Higher scores indicate greater capacity to implement an sustain lung cancer screening activities.
Up to 3 Years
Study Arms (1)
Health Services Research (SBI Intervention)
EXPERIMENTALParticipants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the MSLCRT and NLCC during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.
Interventions
Participants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the MSLCRT and NLCC during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.
Eligibility Criteria
You may qualify if:
- Member of a state-based lung cancer screening implementation team in Mississippi or Nevada.
- Leadership member of the Mississippi state team or Nevada state team
- Active member of the Mississippi Lung Cancer Roundtable (MSLCRT) or Nevada Lung Cancer Coalition (NLCC)
- Willing to participate in study-related assessments an implementation activities
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Timothy Mullettlead
Study Sites (13)
Delta Health System
Greenville, Mississippi, 38703, United States
Greenwood Leflore Hospital
Greenwood, Mississippi, 38930, United States
Memorial Hospital Gulfport
Gulfport, Mississippi, 39501, United States
Hattiesburg Clinic
Hattiesburg, Mississippi, 39401, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
Baptist Memorial Hospital
New Albany, Mississippi, 38652, United States
North Mississippi Health Services
Tupelo, Mississippi, 38801, United States
Mt. Grant General Hospital
Hawthorne, Nevada, 89415, United States
Desert View Hospital
Pahrump, Nevada, 89048, United States
Renown Regional Medical Center
Reno, Nevada, 89502, United States
Sierra Medical Center
Reno, Nevada, 89511, United States
Sunrise Health
Winchester, Nevada, 89109, United States
Humboldt General Hospital
Winnemucca, Nevada, 89445, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 26, 2026
First Posted
July 6, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2029
Last Updated
July 6, 2026
Record last verified: 2026-06